CS
Catherine Schulte Baird Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
32
Avg Return
Past Year
Past Year
3.9%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
68.8%
Neutral
31.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $142 |
3%
downside
| 3 | +4.2% |
0
%
| 28 Aug ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $1,230 |
11%
downside
| 5 | – |
–
| 4 Aug ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $15 |
4%
downside
| 4 | -3.8% |
0
%
| 4 Aug ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $567 |
2%
upside
| 4 | +0.68% |
0
%
| 24 Jul ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $229 |
4%
upside
| 6 | -2.2% |
0
%
| 23 Jul ‘25 3 months ago |
|
|
|
Neutral
Maintained
| $2 |
41%
downside
| 3 | -60% |
0
%
| 13 May ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $72 |
14%
upside
| 2 | +0.2% |
0
%
| 2 May ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $43 |
11%
downside
| 2 | – |
–
| 21 Apr ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $68 |
7%
upside
| 3 | -7.1% |
0
%
| 19 Feb ‘25 8 months ago |
|